You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API dapagliflozin and metformin hydrochloride

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing dapagliflozin and metformin hydrochloride

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
AstraZeneca Pharmaceuticals LP	XIGDUO	dapagliflozin and metformin hydrochloride	0310-6270	ANHYDROUS LACTOSE	2031-05-12
AstraZeneca Pharmaceuticals LP	XIGDUO	dapagliflozin and metformin hydrochloride	0310-6270	CARBOXYMETHYLCELLULOSE SODIUM	2031-05-12
AstraZeneca Pharmaceuticals LP	XIGDUO	dapagliflozin and metformin hydrochloride	0310-6270	CELLULOSE, MICROCRYSTALLINE	2031-05-12
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for dapagliflozin and metformin hydrochloride

Excipient focus: ANHYDROUS LACTOSE

dapagliflozin and metformin hydrochloride drug variants containing ANHYDROUS LACTOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	dapagliflozin and metformin hydrochloride	0310-6270
PRASCO LLC	dapagliflozin and metformin hydrochloride	66993-362
>Company	>Ingredient	>NDC

dapagliflozin and metformin hydrochloride drug variants not containing ANHYDROUS LACTOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

dapagliflozin and metformin hydrochloride drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	dapagliflozin and metformin hydrochloride	0310-6270
PRASCO LLC	dapagliflozin and metformin hydrochloride	66993-362
>Company	>Ingredient	>NDC

dapagliflozin and metformin hydrochloride drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE, MICROCRYSTALLINE

dapagliflozin and metformin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	dapagliflozin and metformin hydrochloride	0310-6270
PRASCO LLC	dapagliflozin and metformin hydrochloride	66993-362
>Company	>Ingredient	>NDC

dapagliflozin and metformin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSPOVIDONE

dapagliflozin and metformin hydrochloride drug variants containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	dapagliflozin and metformin hydrochloride	0310-6270
PRASCO LLC	dapagliflozin and metformin hydrochloride	66993-362
>Company	>Ingredient	>NDC

dapagliflozin and metformin hydrochloride drug variants not containing CROSPOVIDONE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE 2208

dapagliflozin and metformin hydrochloride drug variants containing HYPROMELLOSE 2208

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	dapagliflozin and metformin hydrochloride	0310-6270
PRASCO LLC	dapagliflozin and metformin hydrochloride	66993-362
>Company	>Ingredient	>NDC

dapagliflozin and metformin hydrochloride drug variants not containing HYPROMELLOSE 2208

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

dapagliflozin and metformin hydrochloride drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	dapagliflozin and metformin hydrochloride	0310-6270
PRASCO LLC	dapagliflozin and metformin hydrochloride	66993-362
>Company	>Ingredient	>NDC

dapagliflozin and metformin hydrochloride drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

dapagliflozin and metformin hydrochloride drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
AstraZeneca Pharmaceuticals LP	dapagliflozin and metformin hydrochloride	0310-6270
PRASCO LLC	dapagliflozin and metformin hydrochloride	66993-362
>Company	>Ingredient	>NDC

dapagliflozin and metformin hydrochloride drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.